hesperidin has been researched along with gw9662 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, YO; Arya, DS; Goyal, SN; Sharma, PK; Shrivastava, B | 1 |
| Agrawal, YO; Arya, DS; Goyal, SN; Ojha, S; Sharma, PK; Shrivastava, B; Upadhya, HM | 1 |
2 other study(ies) available for hesperidin and gw9662
| Article | Year |
|---|---|
Hesperidin blunts streptozotocin-isoproternol induced myocardial toxicity in rats by altering of PPAR-γ receptor.
Topics: Anilides; Animals; Catalase; Creatine Kinase, MB Form; Diabetes Mellitus, Experimental; Female; Glutathione; Hesperidin; Isoproterenol; L-Lactate Dehydrogenase; Male; Microscopy, Electron, Transmission; Myocardial Infarction; PPAR gamma; Random Allocation; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Troponin I | 2014 |
Hesperidin produces cardioprotective activity via PPAR-γ pathway in ischemic heart disease model in diabetic rats.
Topics: Anilides; Animals; bcl-2-Associated X Protein; Cardiotonic Agents; Creatine Kinase, MB Form; Diabetes Mellitus, Experimental; Disease Models, Animal; Hemodynamics; Hesperidin; Lipid Peroxidation; Male; Microscopy, Electron, Transmission; Myocardial Ischemia; Myocardium; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2014 |